Pharmaceutical Lawsuit and Recall Information
At RxRecall.com, our pharmaceutical litigation and defective drug lawyers are committed to serving personal injury victims and are well versed in the product liability laws that protect consumers.
Recently accused of illegally marketing the drug, Detrol, the world’s biggest drug maker, Pfizer, has agreed to pay the U.S. government $14.5 million to settle the charges, according to the U.S. Attorney’s Office in Boston. Pfizer allegedly marketed their overactive bladder drug, Detrol, for the treatment of men with enlarged prostates and other related conditions, [...]
The consumer watchdog group, Public Citizen, this week asked the U.S. Food and Drug Administration not to approve the drug, rivaroxaban (Xarelto), for use in patients with atrial fibrillation, citing concerns over the drug’s overall safety and efficacy. The group issued a letter to the FDA, specifically addressing a recent discrepancy in opinion between an [...]
Unfortunately, the use of certain prescription drugs during pregnancy can greatly increase the risk of birth defects in newborns. In fact, two FDA-approved epilepsy medications, Keppra and Lamictal, are examples of the type of prescription medications that could cause harm when taken in pregnancy. Currently, both Lamictal and Keppra are listed as Category C drugs, [...]
Earlier this week, the U.S. Food and Drug Administration issued a warning letter to drug-maker, GlaxoSmithKline, citing several manufacturing violations found during a March 2011 inspection of the company’s drug-manufacturing plant in the United Kingdom. More specifically, federal regulators say the company failed to establish proper procedures that would prevent the microbiological contamination of their [...]
With Halloween fast approaching, the FDA has this week released a consumer safety warning regarding costume contact lenses. The agency is reminding the public that while over-the-counter fashion lenses may enhance the holiday fun, they are dangerous and could potentially lead to serious vision-threatening problems. According to federal regulators, contact lenses are medical devices that [...]
Johnson and Johnson’s Ortho-McNeil-Janssen Pharmaceutical unit is still under fire in New Jersey state court this week, as closing arguments wrap-up regarding the risks associated with use of the company’s popular antibiotic, Levaquin. Specifically, plaintiffs allege that the J&J unit never fully warned patients of the serious risk for tendon damage associated with use of [...]
New research released this week highlights the growing concern about long-term use of vitamin supplements by those who do not suffer from nutritional deficiencies. In fact, according to the results of two new studies, high doses of vitamins may actually do more harm than good. As reported in The Journal of the American Medical Association, [...]
The U.S. Food and Drug Administration recently issued a new drug safety communication, in which the agency reported that the Bristol-Myers Squibb leukemia drug, Sprycel, could potentially increase a patient’s risk for developing a rare high blood pressure problem in the lungs, known as pulmonary arterial hypertension, or PAH. PAH is a condition that causes [...]
Avastin, one of the world’s most popular cancer drugs, has been under intense scrutiny by the FDA while the agency works to determine whether or not to pull its approval of the drug as a treatment for breast cancer. In an effort to save one of its best-selling products, the drug’s manufacturer, Roche, has asked [...]
One of the largest manufacturers of generic drugs, Teva Pharmaceuticals, was recently accused of placing profit ahead of the safety of colonoscopy patients using their anesthetic, Propofol. Teva, along with its distrutors, Baxter International and McKesson Corporation, are being sued for marketing and selling Propofol in jumbo-sized vials, knowing that doctors would possibly reuse the [...]
